CADD in Cardiovascular Drug Discovery
Cardiovascular diseases (CVDs) are among the major causes of morbidity and mortality worldwide, creating a continuous need for the development of safer, more effective, and targeted therapies. Computer-Aided Drug Design (CADD) has emerged as an important computational approach in cardiovascular drug discovery by reducing the time, cost, and experimental effort involved in conventional drug development. This report provides an overview of the application of CADD in cardiovascular drug discovery, including Structure-Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD), molecular docking, molecular dynamics simulations, quantitative structure–activity relationship (QSAR) modelling, virtual screening, pharmacophore modelling, and ADMET prediction. CADD can be applied to important cardiovascular targets such as angiotensin-converting enzyme (ACE), HMG-CoA reductase, PCSK9, phosphodiesterase, β-adrenergic receptors, and ion channels. It also supports the development and optimization of cardiovascular drug delivery systems such as drug-eluting stents, drug-coated balloons, liposomes, and nanoparticles. The integration of artificial intelligence (AI) and machine learning (ML) with CADD further improves molecular screening, activity prediction, ADMET assessment, drug design, and personalized drug delivery. Despite its advantages, CADD has limitations including data quality, biological complexity, difficulties in modelling cardiovascular physiology, computational requirements, lack of standardization, and the need for experimental validation. Therefore, computational predictions must be supported by in-vitro, in-vivo, and clinical studies. Future developments involving AI/ML, multi-omics, digital twins, hybrid multiscale modelling, and patient-specific computational approaches may further improve cardiovascular drug discovery and delivery. Overall, CADD provides a valuable framework for developing safer, more efficient, and potentially personalized cardiovascular therapies.
Authors
- Sanika Sabale
- Prasad Yadav
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24414464
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00